PATENT CLAIM ANALYSIS

Application Number: 15904845
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "184100"]

Abstract:
The present invention provides the use of metagenomics to identify a compositional or functional alteration of the gut metagenome related to atherosclerosis or atherosclerotic associated disease. Also provided are methods to identify a person having risk for atherosclerosis and associated diseases by determining the presence of specific bacterial groups or species and also metabolic functions in the person's gut microbiota and to use such information to develop a prevention or treatment strategy.

Claim (Index 49):
The method of  claim 48 , wherein the \u03b2-carotene is a \u03b2-carotene supplement or a probiotic bacteria producing \u03b2-carotene.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.44231
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14651550', '15017087', '12566965', '13214034', '15090609']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7360784122826709
- 35 USC 102 Novelty (BERT): 0.5194067519655029
- Combined Prediction Score: 0.7144112462509542
- Mean Citation Score: 237.38777400000004
- Max Citation Score: 286.95468
- Similarity Product: 176.1896497322559

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test